17β-Estradiol treatment retards excitotoxic delayed degeneration in substantia nigra reticulata neurons

被引:8
作者
DeGiorgio, LA
Attardi, B
Shimizu, Y
Ogata, M
Volpe, BT
机构
[1] Cornell Univ, Weil Med Coll, Dept Neurol & Neurosci, Burke Med Res Inst, White Plains, NY 10605 USA
[2] Bioqual Inc, Rockville, MD 20850 USA
关键词
excitotoxic delayed neuronal degeneration; estrogen; neuroprotection; substantia nigra;
D O I
10.1016/S0006-8993(02)02482-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Estrogen treatment offers neuro-protection in animal experiments in which excitotoxic mechanisms destroy neurons. In a model of delayed neuronal degeneration that depends on excitotoxicity, we tested whether females had an altered susceptibility, and whether physiologic doses of estrogen administered after the brain insult would protect susceptible neurons. Females were ovariectomized, exposed to striatal-pallidal ibotenic acid injury that caused delayed degeneration of substantia nigra neurons, and treated with 17beta-estradiol (30 mug, subcutaneously every other day, beginning 2 days after the striatal injury) or vehicle. At 6 and 8 days post lesion, the 17beta-estradiol treatment group maintained over 87 and 70% of control nigral neuron number, respectively. Physiologic levels of estrogen delivered days after the excitotoxic stress completely protected neurons in the substantia nigra reticulata 6 days post lesion and slowed degeneration 8 days post lesion. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 35 条
[1]   Gender-linked brain injury in experimental stroke [J].
Alkayed, NJ ;
Harukuni, I ;
Kimes, AS ;
London, ED ;
Traystman, RJ ;
Hurn, PD .
STROKE, 1998, 29 (01) :159-165
[2]  
BEDARD P, 1977, LANCET, V2, P1367
[3]   Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion [J].
DeGiorgio, LA ;
DeGiorgio, N ;
Volpe, BT .
NEUROSCIENCE, 1999, 90 (01) :79-85
[4]   Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury [J].
DeGiorgio, LA ;
Dibinis, C ;
Milner, TA ;
Saji, M ;
Volpe, BT .
BRAIN RESEARCH, 1998, 795 (1-2) :1-9
[5]   Estradiol protects against ischemic injury [J].
Dubal, DB ;
Kashon, ML ;
Pettigrew, LC ;
Ren, JM ;
Finklestein, SP ;
Rau, SW ;
Wise, PM .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (11) :1253-1258
[6]   Neuroprotection by estradiol [J].
Garcia-Segura, LM ;
Azcoitia, I ;
DonCarlos, LL .
PROGRESS IN NEUROBIOLOGY, 2001, 63 (01) :29-60
[7]   Neuroprotective effects of estrogens: potential mechanisms of action [J].
Green, PS ;
Simpkins, JW .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (4-5) :347-358
[8]   Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells [J].
Gridley, KE ;
Green, PS ;
Simpkins, JW .
BRAIN RESEARCH, 1997, 778 (01) :158-165
[9]   Estrogen as a neuroprotectant in stroke [J].
Hurn, PD ;
Macrae, IM .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (04) :631-652
[10]   Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium [J].
Improta-Brears, T ;
Whorton, AR ;
Codazzi, F ;
York, JD ;
Meyer, T ;
McDonnell, DP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4686-4691